pathologist
h
e
like
clinician
h
p
histori
physic
basic
examin
perform
everi
specimen
patient
form
cornerston
diagnosi
howev
pathologist
longer
limit
h
e
wide
varieti
special
studi
avail
evalu
patholog
process
simpl
histochem
stain
global
gene
express
pattern
pathologist
clinic
cell
biologist
familiar
type
special
studi
avail
import
initi
process
gross
specimen
may
limit
type
studi
perform
almost
histochem
stain
suitabl
use
formalinfix
tissu
common
stain
use
list
tabl
melanin
argentaffin
granul
chromaffin
identif
melanin
melanoma
granul
lipofuscin
black
secretori
granul
neuroendocrin
nuclei
red
tumor
use
stain
larg
replac
immunohistochemistri
period
acidschiff
except
glycogen
digest
identif
glycogen
tumor
diastas
digest
stain
identif
fungu
glycogenrich
tissu
pasd
eg
skin
pasd
resist
deposit
liver
present
antitrypsin
defici
phosphotungist
acidhematoxylin
glial
fiber
blue
identif
neural
lesion
skelet
muscl
mallori
ptah
nuclei
blue
differenti
zenker
fix
prefer
neuron
salmon
pink
stain
replac
ihc
myelin
blue
muscl
marker
skelet
muscl
crossstriat
blue
fibrin
blue
collagen
redbrown
webpath
section
univers
utah
site
http
medlibmedutahedu
use
descript
special
stain
illustr
photograph
develop
method
detect
antigen
tissu
section
antibodi
major
advanc
surgic
patholog
immunohistochem
ihc
studi
frequent
use
follow
purpos
classif
tumor
eg
carcinoma
versu
lymphoma
bcell
versu
tcell
lymphoma
identif
situ
lesion
versu
invas
eg
myoepitheli
marker
breast
cancer
basal
cell
marker
prostat
prognost
factor
eg
glioblastoma
predict
factor
guid
specif
therapi
eg
ckit
estrogen
progesteron
receptor
identif
extracellular
materi
eg
microglobulin
amyloid
identif
infecti
agent
eg
cytomegaloviru
differenti
diagnosi
gener
examin
h
e
stain
slide
immunohistochemistri
use
gain
evid
diagnost
possibl
troll
case
immunohistochemistri
laboratori
order
numer
antibodi
studi
without
clear
reason
mind
like
lead
misguid
diagnosi
due
aberr
immunoreact
provid
unexpect
correct
diagnosi
use
websit
develop
dr
denni
frisman
http
wwwimmunoquerycom
tabul
publish
literatur
immunoreact
profil
numer
tumor
also
comprehens
list
includ
refer
web
link
absolut
rule
immunoreact
cell
tissu
aberr
posit
immunoreact
absenc
immunoreact
occasion
observ
antibodi
either
due
biolog
variabl
eg
occasion
keratinposit
melanoma
technic
factor
impur
antibodi
crossreact
antigen
failur
preserv
antigen
thu
immunohistochem
marker
use
effect
panel
marker
interpret
base
immunohistochem
profil
tissu
often
dislodg
normal
glass
slide
treatment
requir
ihc
slide
must
coat
eg
glue
polyllysin
gelatin
albumin
special
commerci
slide
must
use
slide
prepar
anoth
laboratori
type
glass
slide
use
must
specifi
numer
variabl
affect
antigen
common
describ
laboratori
must
optim
procedur
antibodi
use
studi
tissu
slide
prepar
routin
fashion
laboratori
must
interpret
caution
type
antibodi
polyclon
versu
monoclon
versu
mixtur
differ
monoclon
epitop
detect
differ
result
obtain
differ
antibodi
protein
differ
commerci
sourc
antibodi
temperatur
bake
slide
control
essenti
appropri
interpret
immunohistochem
studi
ensur
step
complic
procedur
adequ
perform
posit
control
tissu
known
immunoreact
includ
time
antibodi
use
test
case
intern
posit
control
alway
evalu
present
control
techniqu
use
also
antigen
tissu
investig
tabl
see
pp
list
normal
cell
gener
immunoreact
antibodi
laboratori
use
vimentin
control
immunogen
almost
tissu
demonstr
posit
given
wide
nonspecif
distribut
vimentin
smooth
muscl
may
use
context
pericyt
vascular
smooth
muscl
myoepitheli
cell
present
tissu
immunoreact
exampl
intern
control
normal
nerv
melanocyt
langerhan
cell
epidermi
cartilag
myoepitheli
cell
skin
adnexa
neg
control
primari
antibodi
replac
nonimmun
anim
serum
dilut
concentr
primari
antibodi
neg
control
posit
reaction
present
multipl
primari
antibodi
reactiv
differ
target
antigen
use
may
serv
neg
control
although
best
neg
control
would
use
antibodi
preabsorb
target
antigen
rare
practic
diagnost
laboratori
diagnost
slide
also
evalu
intern
neg
control
aberr
immunoreact
tissu
immunoreact
indic
immunoreact
nonspecif
use
interpret
follow
featur
must
taken
consider
evalu
immunoperoxidas
studi
exampl
nuclear
er
membran
ema
ecadherin
egfr
cytoplasm
actin
keratin
stromal
amyloid
microglobulin
calcitonin
lambda
chain
rare
case
immunoreact
unusu
locat
diagnost
import
adenoma
thyroid
scleros
hemangioma
lung
betacatenin
nuclear
instead
cytoplasm
posit
solidpseudopapillari
tumor
pancrea
pancreaticoblastoma
nuclear
cytoplasm
posit
seen
major
colon
carcinoma
nuclear
posit
present
approxim
endometrioid
endometri
carcinoma
identif
immunoreact
cell
immunoreact
tumor
cell
must
distinguish
immunoreact
normal
entrap
cell
eg
desminposit
skelet
muscl
cell
infiltr
tumor
langerhan
cell
tumor
smooth
muscl
blood
vessel
etc
plasma
cell
larg
amount
cytoplasm
immunoglobulin
react
nonspecif
mani
antibodi
intens
immunoreact
weak
immunoreact
may
present
nonspecif
find
import
compar
posit
cell
control
slide
normal
nonimmunoreact
cell
determin
whether
immunoreact
signific
case
number
posit
cell
may
import
criterion
posit
prognost
marker
eg
marker
prolifer
case
rare
weakli
posit
cell
must
distinguish
intermingl
normal
cell
nonspecif
immunoreact
criteria
posit
result
specif
criteria
evalu
ihc
develop
antibodi
see
tabl
howev
criteria
exist
antibodi
univers
use
pathologist
signific
immunoreact
vari
type
lesion
antibodi
specif
assay
strong
posit
major
cell
easili
interpret
posit
result
number
posit
cell
decreas
intens
immunoreact
weaken
lower
threshold
posit
result
becom
difficult
determin
time
alkalin
phosphatas
chromogen
red
color
fade
time
dab
brown
color
perman
problem
evalu
current
patholog
specimen
howev
immunoperoxidas
slide
review
period
time
chromogen
may
fade
onceposit
result
may
appear
neg
fig
antigen
present
specif
site
antigen
may
present
one
locat
extracellular
artifact
nonspecif
posit
suspect
immunoreact
present
atyp
locat
background
suspect
nonspecif
posit
normal
cell
stroma
posit
occur
suboptim
perform
assay
suboptim
antibodi
edg
artifact
antibodi
pool
edg
hole
tissu
true
posit
also
present
center
tissu
necrosi
crush
cell
nonspecif
posit
seen
disrupt
cell
although
keratin
gener
reliabl
necrot
tumor
marker
gener
interpret
inappropri
locat
eg
cytoplasm
instead
nucleu
occasion
er
pr
present
cytoplasm
instead
nucleu
interpret
posit
result
tabl
includ
inform
literatur
well
person
experi
staff
brigham
women
hospit
mani
differ
specif
antibodi
laboratori
assay
criteria
consid
result
posit
result
may
vari
among
institut
result
divid
five
categori
gener
marker
four
categori
hematopatholog
marker
tabl
note
refer
number
tumor
report
posit
number
cell
posit
within
tumor
actual
marker
use
evalu
case
depend
upon
differenti
diagnosi
base
h
e
appear
case
initi
panel
often
use
typic
case
suggest
marker
list
would
use
case
marker
tabl
predominantli
tumor
cam
ck
ema
bercea
cea
chro
hep
tabl
predominantli
tumor
cam
ck
ema
bercea
cea
chro
hep
calci
po
may
posit
breast
basal
like
carcinoma
spindl
cell
metaplast
carcinoma
squamou
cell
carcinoma
papillari
carcinomasthes
subtyp
may
also
less
typic
keratin
subset
detect
detect
b
well
moder
differenti
ductal
carcinoma
carcinoma
special
type
except
medullari
posit
hormon
receptor
poorli
differenti
carcinoma
metaplast
carcinoma
medullari
carcinoma
usual
negativewel
moder
differenti
lobular
carcinoma
almost
alway
posit
er
usual
posit
pr
poorli
differenti
lobular
carcinoma
may
neg
marker
c
nonmucin
bronchioloalveolar
carcinoma
bal
immunophenotyp
similar
lung
adenocarcinoma
mucin
bal
like
posit
approxim
posit
less
like
posit
approxim
posit
secretori
meningioma
frequent
posit
cea
wherea
subtyp
usual
neg
ceath
major
type
meningioma
posit
pr
includ
meningioma
male
e
mix
tumor
pleomorph
adenoma
occur
frequent
salivari
gland
also
aris
soft
tissu
myoepitheli
tumor
soft
tissu
tumor
similar
immunophenotyp
keratin
pank
ema
present
major
tumor
frequent
express
marker
associ
myoepitheli
cell
eg
calponin
gfap
sma
howev
seen
less
frequent
compar
salivari
tumor
f
chromophob
renal
cell
carcinoma
may
posit
type
neg
tabl
predominantli
tumor
cam
ck
ema
bercea
cea
chro
hep
h
keratin
posit
angiosarcoma
common
epithelioid
type
cellular
dermatofibroma
may
show
focal
desmin
immunoreact
j
alveolar
softpart
sarcoma
character
transloc
fuse
transcript
factor
gene
novel
gene
call
asplthes
sarcoma
demonstr
nuclear
immunoreact
rare
pediatr
renal
tumor
transloc
immunoreact
present
tumor
normal
tissuesth
characterist
cytoplasm
crystal
compos
monocarboxyl
transport
chaperon
howev
protein
found
mani
cell
type
specif
tumor
k
keratin
ema
posit
usual
focal
monophas
synovi
sarcoma
l
posit
glandular
area
synovi
sarcoma
less
spindl
cell
area
immunohistochem
pattern
epithelioid
mesothelioma
given
tabl
n
may
posit
minor
epithelioid
compon
sarcomatoid
mesothelioma
gener
neg
spindl
cell
secretori
meningioma
typic
cytokeratin
posit
neg
also
posit
cea
subtyp
gener
neg
keratin
howev
malign
meningioma
may
posit
keratin
p
squamou
cell
carcinoma
spindl
cell
morpholog
gener
strongli
posit
less
commonli
cam
ema
spindl
cell
carcinoma
breast
often
express
marker
express
myoepitheli
cell
basal
keratin
includ
cytokeratin
includ
group
detect
pank
smooth
muscl
poorli
differenti
carcinoma
spindl
cell
morpholog
may
show
focal
posit
keratin
ema
although
use
tumor
past
studi
current
usual
perform
c
also
frequent
posit
melanoma
small
cell
carcinoma
lung
posit
e
merkel
cell
carcinoma
demonstr
dotlik
perinuclear
pattern
marker
f
signific
immunoreact
membran
pattern
major
cell
g
plasma
cell
lymphoma
may
posit
ewe
sarcoma
pnet
desmoplast
small
round
cell
tumor
rhabdomyosarcoma
neuroblastoma
medulloblastoma
characterist
cytogenet
chang
see
tabl
em
advantag
immunohistochemistri
evalu
childhood
small
round
blue
cell
tumor
initi
panel
keratin
lca
addit
studi
may
help
depend
histolog
appear
result
initi
studi
case
paget
diseas
nippl
associ
dci
deeper
breast
involv
lactifer
sinus
approxim
half
also
area
invas
rare
case
may
difficult
interpret
due
absenc
associ
diseas
breast
initi
biopsi
shallow
case
paget
cell
may
take
melanin
may
difficult
distinguish
melanomatok
cell
nippl
epidermi
cam
posit
neg
initi
panel
cam
addit
antibodi
studi
base
find
necessari
case
extramammari
paget
diseas
like
posit
less
like
posit
less
also
sometim
posit
good
gener
marker
myoepitheli
cell
particularli
help
case
promin
myofibroblast
eg
scleros
lesion
blood
vessel
close
appos
tumor
cell
eg
papillari
frond
papillari
dci
case
sma
may
posit
cell
tabl
renal
cell
carcinoma
subtyp
typic
cytogenet
abnorm
see
tabl
ckit
report
posit
almost
papillari
renal
cell
carcinoma
cytoplasm
chromophob
carcinoma
membran
present
clear
cell
carcinoma
mutat
ckit
found
papillari
carcinoma
carcinoma
membran
cytoplasm
pattern
b
seen
cytoplasm
unlik
nuclear
pattern
seen
lung
thyroid
carcinoma
c
carcinoid
aris
site
lung
unlik
posit
lung
carcinoid
may
posit
like
express
sinusoid
hcc
show
diffus
posit
case
seen
normal
liver
posit
also
seen
focal
nodular
hyperplasia
metastat
carcinoma
show
diffus
posit
case
posit
endotheli
cell
present
throughout
tumor
cell
surround
nest
tumor
cell
seen
hcc
reticulin
stain
help
evalu
fine
needl
aspir
core
needl
biopsi
liver
lesion
hcc
abnorm
pattern
absent
decreas
expand
trabecula
wherea
benign
lesion
show
normal
trabecular
pattern
metastat
carcinoma
usual
distinguish
hcc
frequent
express
rare
express
absenc
bile
canalicular
pattern
cea
p
absenc
cytoplasm
posit
metastat
carcinoma
liver
often
reliabl
distinguish
cholangiocarcinoma
histolog
appear
immunohistochem
pattern
except
colorect
carcinoma
patient
known
primari
carcinoma
help
compar
two
tumor
thyroid
adenoma
follicular
carcinoma
papillari
carcinoma
medullari
carcinoma
posit
negativevari
immunoreact
report
anaplast
carcinoma
metastat
carcinoma
thyroid
neg
thyroglobulin
except
lung
carcinoma
calcitonin
new
marker
may
prove
help
distinguish
follicular
carcinoma
approxim
posit
adenoma
neg
lymphoplasmacyt
precursor
adult
tcell
anaplast
larg
specif
characterist
h
e
appear
usual
suffici
reveal
keratin
product
intercellular
bridg
radiat
therapi
often
effect
hpv
hpv
commonli
present
carcinoma
cervix
may
seen
carcinoma
site
eg
basaloid
carcinoma
tonsil
approxim
patient
cervic
lymph
node
metastasi
unknown
primari
occult
tonsillar
carcinoma
complet
sampl
tonsil
may
necessari
identifi
small
carcinoma
thyroid
papillari
thyroglobulin
lung
carcinoma
also
posit
thyroglobulin
neg
follicular
carcinoma
highli
effect
treatment
cure
radioact
iodin
thyroid
medullari
calcitonin
palli
treatment
tumordirect
radionucleotid
carcinoma
famili
import
counsel
famili
member
trophoblast
tumor
inhibin
inhibin
specif
trophoblast
tumor
unlik
neg
chemotherapi
possibl
cure
trastuzumab
herceptin
monoclon
antibodi
direct
receptor
b
imatinib
mesyl
gleevec
tm
glivec
tm
small
molecul
tyrosin
kinas
inhibitor
use
cml
ph
gist
kit
protein
encod
ckit
protooncogen
transmembran
receptor
protein
tyrosin
kinas
activ
mutat
protein
may
may
respond
therapi
imatinib
mutat
render
kit
independ
ligand
scf
stem
cell
factor
found
gist
aml
germ
cell
tumor
system
mastocytosiswildtyp
kit
kit
mutat
juxtamembran
domain
intracellular
segment
transmembran
tyrosin
kinas
domain
found
gist
sensit
imatinib
tumor
type
associ
mutat
enzymat
domain
alter
protein
gener
sensit
imatinib
c
gefitinib
iressa
tyrosin
kinas
inhibitor
effect
small
subset
lung
adenocarcinoma
specif
activ
mutat
pathologist
frequent
receiv
specimen
metastat
tumor
often
site
origin
known
clinician
inform
provid
pathologist
good
clinic
histori
frequent
success
correct
classif
batteri
immunoperoxidas
studiesth
pattern
gener
help
narrow
potenti
site
origin
carcinoma
see
tabl
addit
studi
use
identifi
specif
type
carcinomath
import
tumor
identifi
specif
therapeut
treatment
cure
palliat
broadspectrum
keratin
carcinoma
may
express
unusu
keratin
subtyp
neg
tri
pank
keratin
type
eg
cam
pattern
may
help
determin
like
site
origin
noncarcinoma
epithelioid
appear
strongli
express
keratin
eg
epithelioid
angiosarcoma
epithelioid
sarcoma
mesothelioma
melanoma
protein
strongli
posit
vast
major
melanoma
carcinoma
esp
breast
sarcoma
also
posit
addit
marker
may
requir
express
epithelioid
melanoma
may
focal
absent
nonepithelioid
melanoma
eg
spindl
cell
desmoplast
melanoma
leukocyt
common
antigen
present
almost
nonhodgkin
lymphoma
may
absent
anaplast
larg
cell
lymphomasthes
lymphoma
keratin
neg
may
express
emathes
tumor
posit
alk
egfr
assay
approv
fda
select
patient
colorect
carcinoma
treatment
monoclon
antibodi
egfr
cetuximab
erbitux
test
shown
superior
compar
test
unlik
mechan
overexpress
egfr
appear
gene
overexpress
tabl
illustr
suggest
method
score
test
immunoreact
membran
cytoplasm
membran
immunoreact
score
partial
complet
clinic
trial
colorect
carcinoma
posit
patient
posit
result
treat
cetuximab
alon
combin
agent
shown
clinic
respons
patient
carcinoma
score
egfr
treat
correl
found
degre
tumor
respons
percentag
egfrposit
cell
intens
stain
note
mani
normal
cell
also
posit
egfr
notabl
hepatocyt
basal
squamou
cell
delet
loss
delet
highli
variabl
chang
keratin
immunoreact
accentu
around
nucleu
present
cytoplasm
without
promin
membran
accentu
b
keratin
immunoreact
diffus
present
cytoplasm
membran
accentu
cell
c
immunoreact
nuclear
metastat
adenocarcinoma
gener
neg
except
ovarian
serou
carcinoma
renal
carcinoma
see
tabl
e
metastat
adenocarcinoma
posit
cea
except
see
tabl
tissu
obtain
em
cytogenet
possibl
initi
panel
calretinin
clone
cea
addit
studi
order
difficult
case
antibodi
gener
report
neg
epitheli
mesothelioma
posit
lung
adenocarcinoma
includ
follow
cytokeratin
report
posit
mesothelioma
neg
lung
carcinoma
howev
experi
marker
proven
less
use
list
aboveth
use
ema
controversi
strong
membran
posit
characterist
epitheli
mesothelioma
wherea
cytoplasm
posit
characterist
adenocarcinoma
less
known
immunophenotyp
pure
sarcomatoid
mesotheliomasth
spindl
cell
posit
cytokeratin
less
frequent
posit
marker
compar
epithelioid
cellstumor
occas
resembl
mesothelioma
gener
neg
cytokeratin
notabl
except
case
angiosarcoma
epithelioid
hemangioendothelioma
synovi
sarcoma
epithelioid
sarcoma
leiomyosarcoma
see
tabl
carcinoma
express
diminish
highergrad
lesion
peripher
tcell
neoplasm
anaplast
larg
cell
lymphoma
often
neg
ss
dna
nucleu
lymphoma
associ
protein
polymorphonuclear
lymphoma
antigen
express
leukocyt
eosinophil
cell
cytoplasm
result
immunoperoxidas
studi
incorpor
surgic
patholog
report
follow
inform
includ
type
tissu
studi
formalinfix
fix
tissu
cryostat
section
cytolog
prepar
etc
type
immunoag
use
specif
possibl
exampl
list
keratin
specifi
type
keratin
eg
result
studi
suffici
detail
allow
interpret
exampl
type
cell
immunoreact
eg
tumor
versu
nontumor
intens
immunoreact
eg
weak
strong
andor
number
cell
immunoreact
eg
focal
versu
diffus
integr
result
final
diagnosi
specifi
whether
confirm
support
diagnosi
make
one
diagnosi
like
other
exclud
one
diagnos
em
continu
import
role
surgic
patholog
diagnost
renal
biopsi
glomerular
diseas
adenocarcinoma
versu
mesothelioma
see
tabl
difficult
classifi
tumor
tabl
nerv
eg
toxic
druginduc
neuropathi
muscl
biopsi
eg
inclus
bodi
nemalin
myopathi
bullou
skin
diseas
eg
epidermolysi
bullosa
ciliari
dysmorpholog
primari
ciliari
dyskinesia
kartagen
syndrom
endomyocardi
biopsi
eg
adriamycin
toxic
amyloid
nemalin
liver
biopsi
microvesicular
fat
acut
fatti
liver
pregnanc
small
bowel
biopsi
look
pathogen
eg
whippl
diseas
congenit
inherit
metabol
diseas
eg
ceroid
lipofuscinos
prion
diseas
ultrastructur
detail
tissu
rapidli
lost
therefor
fresh
tissu
must
fix
rapidli
well
em
tissu
usual
fix
special
fix
em
preserv
lipid
glycogen
eg
paraformaldehyd
glutaraldehyd
cacodyl
buffer
ph
cut
surfac
cut
tissu
multipl
tini
fragment
greater
cm
dimens
place
tissu
vial
fix
shake
vial
make
sure
tissu
fragment
cover
fix
note
tissu
small
biopsi
found
nondiagnost
h
e
tissu
save
em
retriev
examin
light
microscopi
separ
em
report
usual
issu
result
incorpor
final
diagnosi
frozen
tissu
use
immunoperoxidas
stain
antibodi
detect
antigen
frozen
tissu
enzym
studi
muscl
biopsi
save
tissu
dna
rna
studi
frozen
tissu
use
specimen
question
lymphoprolif
disord
sarcoma
unusu
tumor
muscl
biopsi
small
approxim
cm
portion
tissu
place
clean
specimen
contain
moisten
small
amount
normal
salin
frozen
glass
beaker
lower
gentli
flask
contain
liquid
nitrogen
isopentan
readi
use
liquid
base
frozen
solid
white
particl
appear
remain
liquid
viscou
remov
beaker
flask
care
use
forcep
drop
small
piec
tissu
directli
isopentan
freez
tissu
approxim
second
remov
tissu
forcep
quickli
wrap
aluminum
foil
place
tissu
label
freezer
bag
place
flask
contain
liquid
nitrogen
transfer
specimen
bag
flask
freezer
insuffici
tissu
snap
freez
frozen
section
consult
room
may
save
frozen
potenti
studi
mani
cryostat
undergo
automat
defrost
cycl
tissu
left
block
cryostat
thaw
refreez
thu
tissu
save
frozen
transfer
freezer
result
immunoperoxidas
studi
frozen
tissu
usual
incorpor
surgic
patholog
report
like
immunoperoxidas
studi
immunofluoresc
detect
antigen
tissu
howev
amplif
signal
use
better
suit
precis
local
antigenantibodi
complex
tissu
determin
deposit
pattern
immun
complex
eg
linear
versu
granular
thu
use
investig
diseas
relat
immun
complex
deposit
glomerular
diseas
bullou
diseas
skin
tissu
immunofluoresc
may
snap
frozen
see
instruct
store
special
fix
specimen
frozen
special
care
must
taken
ensur
biopsi
kept
moist
seal
contain
direct
use
antibodi
detect
antigen
patient
tissu
indirect
use
control
tissu
detect
antibodi
eg
antibm
patient
serum
biopsi
skin
diseas
eg
lupu
pemphigu
pemphigoid
dermat
herpetiformi
diagnost
nontranspl
renal
biopsi
transplant
renal
biopsi
evalu
vascul
nerv
biopsi
tissu
must
submit
fresh
result
examin
usual
incorpor
surgic
patholog
report
linear
granular
stain
along
dermalepiderm
junction
multipl
immunoreact
commonli
igg
less
often
igm
approxim
case
specif
increas
number
posit
immunoreact
uninvolv
sunexpos
skin
show
posit
patient
activ
system
lupu
uninvolv
skin
patient
discoid
lupu
usual
neg
test
herp
gestationi
perilesion
skin
show
linear
basement
membran
zone
sometim
igg
dermat
herpetiformi
granular
iga
seen
tip
dermal
papilla
uninvolv
skin
pemphigu
igg
epiderm
cell
creat
netlik
pattern
pemphigu
vulgari
split
basal
cell
layer
creat
tombston
appear
row
basal
cell
base
addit
inform
see
also
vesicl
pemphigu
foliaceu
relat
disord
split
occur
near
granular
cell
layer
pemphigoid
ig
present
along
basement
membran
cell
indirect
reveal
antibm
antibodi
molecular
genet
patholog
newest
subspeci
patholog
board
certif
molecular
diagnost
incorpor
mani
type
techniqu
investig
genet
alter
cell
virus
eg
southern
blot
pcr
analysi
fish
applic
three
main
area
identif
inherit
diseas
eg
cystic
fibrosi
hemochromatosi
factor
v
leiden
prothrombin
fragil
x
syndrom
identif
gene
confer
suscept
diseas
eg
detect
organ
identif
specif
organ
quantit
viral
infect
eg
hiv
viral
load
identif
specif
genet
alter
associ
tumor
tabl
identif
clonal
hematolymphoid
prolifer
tabl
detect
minim
residu
diseas
treatment
molecular
genet
studi
especi
help
difficulttoclassifi
hematolymphoid
prolifer
frequent
characterist
rearrang
occur
mani
disord
unlik
cytogenet
cell
need
viabl
howev
prefer
nucleic
acid
rel
intact
southern
blot
rna
base
pcr
rtpcr
assay
best
perform
fresh
frozen
tissu
formalinfix
paraffinembed
tissu
amen
dnabas
pcr
assay
fix
eg
bouin
caus
extens
breakag
dna
may
preclud
genet
analysi
tissu
bcell
prolifer
clonal
rearrang
immunoglobulin
heavi
light
chain
gene
specif
transloc
see
tabl
tcell
prolifer
rearrang
tcell
receptor
gene
leukemia
see
tabl
fresh
frozen
tissu
eg
snapfrozen
tissu
well
fluid
may
use
cytolog
prepar
use
fish
result
usual
either
report
separ
incorpor
surgic
patholog
report
cytogenet
studi
demonstr
use
sever
area
import
patholog
tumor
classif
particularli
sarcoma
lymphoma
brain
tumor
unusu
tumor
ewe
sarcoma
synovi
sarcoma
benign
versu
malign
lesion
exampl
reactiv
mesotheli
cell
versu
mesothelioma
lipoma
versu
liposarcoma
prognosi
exampl
neuroblastoma
multipl
myeloma
research
transloc
common
mani
tumor
usual
identifi
gene
import
pathogenesi
tumor
cell
may
cultur
perform
complet
karyotyp
analysi
tissu
analyz
specif
chromosom
alter
fluoresc
situ
hybrid
fish
fish
studi
perform
cultur
cell
cytolog
prepar
fix
embed
tissu
cytogenet
studi
indic
soft
tissu
tumor
mesothelioma
tissu
pleural
fluid
unusu
tumor
poorli
differenti
tumor
subcutan
lipoma
larger
cm
subfasci
lipoma
karyotyp
oligodendroglioma
fish
tissu
karyotyp
must
fresh
viabl
rel
steril
howev
tissu
may
submit
even
handl
strictli
steril
condit
contamin
usual
problem
specimen
held
overnight
tissu
minc
cube
steril
specimen
contain
cover
cultur
medium
held
overnight
refriger
fluid
may
also
submit
analysi
especi
pleural
effus
suspicion
mesothelioma
result
cytogenet
analysi
incorpor
final
diagnosi
test
use
lung
carcinoma
see
note
c
imatinib
mesyl
gleevec
tm
glivec
tm
small
molecul
tyrosin
kinas
inhibitor
may
use
treatment
tumor
overexpress
tyrosin
kinas
bcrabl
tyrosin
kinas
cml
ph
kit
tyrosin
kinas
gist
system
mastocytosi
type
aml
pdgfr
kinas
cmml
chronic
eosinophil
leukemia
rare
case
gist
kit
protein
encod
ckit
protooncogen
transmembran
receptor
protein
tyrosin
kinas
activ
mutat
may
render
kit
independ
ligand
scf
stem
cell
factor
mutat
protein
may
may
respond
therapi
imatinibwildtyp
kit
kit
mutat
juxtamembran
domain
intracellular
segment
transmembran
tyrosin
kinas
domain
found
gist
sensit
imatinib
tumor
type
associ
mutat
enzymat
domain
alter
protein
gener
sensit
imatinib
overexpress
protein
detect
ihc
gefitinib
iressa
tyrosin
kinas
inhibitor
effect
small
subset
lung
adenocarcinoma
specif
activ
mutat
egfr
ihc
egfr
help
identifi
carcinoma
like
respond
treatment
addit
inform
specif
gene
see
onlin
mendelian
inherit
man
omim
wwwncbinlmnihgov
although
sporad
form
cancer
gener
far
outnumb
case
associ
germlin
mutat
case
appear
site
carcinoma
highli
suggest
known
syndrom
investig
may
warrant
kit
protein
encod
ckit
protooncogen
transmembran
receptor
protein
tyrosin
kinas
activ
mutat
may
render
kit
independ
ligand
scf
stem
cell
factor
mutat
protein
may
may
respond
therapi
imatinibwildtyp
kit
kit
mutat
juxtamembran
domain
intracellular
segment
transmembran
tyrosin
kinas
domain
found
gist
sensit
imatinib
tumor
type
associ
mutat
enzymat
domain
alter
protein
gener
sensit
imatinib
addit
inform
specif
gene
see
onlin
mendelian
inherit
man
omim
wwwncbinlmnihgov
flow
cytomet
analyz
popul
thousand
disaggreg
cell
pass
stationari
detector
cell
size
cytoplasm
granular
measur
well
dna
content
presenc
absenc
immunohistochem
marker
ad
cell
suspens
newer
techniqu
analyz
three
featur
simultan
divid
cell
uniqu
popul
dna
content
use
determin
number
cell
sphase
measur
proliferationsphas
fraction
cell
visual
techniqu
import
sure
lesion
tissu
submit
hydatidiform
mole
complet
diploid
partial
triploid
carcinoma
dna
ploidi
sphase
fraction
report
prognost
signific
carcinoma
eg
colon
breast
prostat
analysi
routin
perform
institut
use
oncologist
lymphoma
leukemia
singl
cell
suspens
necessari
analysi
fresh
tissu
cell
must
viabl
fresh
tissu
approxim
cm
place
specimen
contain
kept
moist
hbss
tissu
held
overnight
refriger
formalinfix
paraffinembed
section
may
also
use
dna
ploidi
analysi
hedley
method
although
result
satisfactori
due
nuclear
fragment
result
usual
incorpor
final
surgic
patholog
report
cytolog
prepar
surgic
specimen
often
provid
addit
inform
intraop
diagnosi
touch
prep
smear
especi
valuabl
infecti
case
avoid
contamin
cryostat
aerosol
infecti
agent
neuropatholog
case
diagnosi
perform
cytogenet
fish
analysi
special
stain
stain
microorgan
perform
day
cytolog
smear
specimen
critic
ill
patient
submit
air
dri
smear
infecti
case
stain
unfix
materi
may
constitut
hazard
laboratori
personnel
fat
dissolv
routin
process
demonstr
fat
stain
air
dri
slide
genet
studi
fish
nuclei
intact
touch
prepar
unlik
tissu
section
partial
nuclei
present
featur
make
touch
prepar
superior
techniqu
fish
imag
analysi
alway
use
exercis
look
cytolog
prepar
correspond
surgic
specimen
learn
compar
morpholog
techniqu
specimen
radiograph
often
prefer
patient
radiograph
perman
record
radiograph
kept
case
radiograph
specimen
may
reveal
detail
underli
process
eg
fewer
structur
may
present
complic
appear
signific
time
interv
may
elaps
patient
radiograph
surgic
excis
radiograph
often
indic
site
import
examin
histolog
tumor
invas
rib
microcalcif
breast
biopsi
specimen
radiograph
confirm
clinic
lesion
remov
tumor
bone
cartilag
tumor
invad
bone
avascular
necrosi
bioprosthet
heart
valv
document
degre
calcif
breast
biopsi
mastectomi
perform
mammograph
lesion
locat
grossli
paraffin
block
breast
tissu
radiograph
microcalcif
seen
specimen
radiographi
histolog
section
identifi
prior
process
calcif
dissolv
formalin
sever
day
demonstr
calcif
import
eg
mammograph
detect
calcif
prefer
process
tissu
within
day
process
delay
tissu
store
ethanol
radiograph
equip
avail
radiolog
depart
patholog
depart
specimen
may
place
piec
wax
paper
keep
surfac
clean
lie
film
specimen
radiograph
decalcif
calcium
remov
best
result
obtain
fresh
undecalcifi
specimen
lung
inflat
prior
radiographi
specimen
small
two
exposur
differ
set
differ
angl
may
use
lead
sheet
use
allow
two
exposur
one
piec
film
film
dark
overexpos
exposur
high
lower
set
tri
film
light
ie
unexpos
exposur
low
higher
set
indic
special
inject
techniqu
radiocontrast
media
avail
unusu
specimen
recipi
lung
pulmonari
hypertens
vascular
ectasia
bowel
octreotid
sentinel
node
label
compound
sometim
use
local
certain
type
tumor
gener
neuroendocrin
sentinel
lymph
node
patient
inject
isotop
prior
surgeri
surgeon
use
handheld
probe
identifi
label
tissu
amount
radioact
tissu
small
gener
pose
hazard
pathologist
handl
tissu
need
special
dispos
method
howev
patholog
depart
consult
radiat
safeti
depart
ensur
appropri
handl
tissu
case
gross
lesion
present
correspond
area
octreotid
uptak
specimen
imag
use
gamma
camera
radiograph
document
gross
descript
inform
gain
radiograph
incorpor
surgic
patholog
report
patholog
depart
uniqu
resourc
research
need
human
tissu
pathologist
play
key
role
patient
advoc
diagnostician
order
provid
appropri
human
tissu
biolog
research
hospit
polici
allow
releas
tissu
research
would
otherwis
discard
therefor
tissu
never
given
away
research
necessari
tissu
taken
diagnosi
tissu
primari
diagnost
breast
biopsi
open
lung
biopsi
without
gross
lesion
given
away
best
interest
patient
pathologist
evalu
specimen
rather
tissu
given
away
nonpathologist
awar
need
diagnosi
perform
requir
surgic
excis
aspir
swab
fluid
tissu
tissu
cultur
amplifi
number
organ
may
rare
organ
present
seen
tissu
section
allow
recogn
specif
organ
categori
organ
identifi
test
recogn
specif
drug
suscept
identif
may
possibl
organ
mani
organ
cultur
identifi
grow
cultur
requir
long
cultur
time
eg
mycobacterium
tuberculosi
may
difficult
exclud
morpholog
evid
contamin
inflammatori
respons
posit
cultur
provid
evid
clinic
infectionth
locat
infect
may
diagnost
import
eg
cellul
versu
necrot
fasciiti
superfici
colon
devit
tissu
versu
deep
infect
involv
viabl
tissu
